Larimar Therapeutics (STU:ZA71) FFO


STU:ZA71 Larimar Therapeutics Inc STU:ZA71
34 GF Score
Price €2.78
! 2 Warning Signs
View Full Analysis

What is Larimar Therapeutics FFO?

FFO (Funds from operations) only applies to REITs.

STU:ZA71
34GF Score
Larimar Therapeutics Inc STU:ZA71
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Larimar Therapeutics Business Description

Other Exchanges LRMR:USAZA71:Germany
Address Three Bala Plaza East, Suite 506, Bala Cynwyd, PA, USA, 19004
Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell penetrating peptide technology platform. Its flagship product candidate, nomlabofusp, is a subcutaneously administered recombinant fusion protein designed to deliver frataxin (FXN) to the mitochondria of patients with Friedreich's ataxia (FA), a rare genetic disease characterized by insufficient production of FXN. The company also plans to use its intracellular delivery platform to design other fusion proteins to target additional rare diseases characterized by deficiencies in intracellular bioactive compounds.
34GF Score

Get the complete analysis for STU:ZA71

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.78
Price